NCT04003272View on ClinicalTrials.gov

MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere

Enrolling by invitationOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

October 28, 2019

Primary Completion Date

August 19, 2034

Study Completion Date

September 1, 2035

Conditions
Shoulder PainShoulder InjuriesShoulder FracturesShoulder ArthritisShoulder Disease
Interventions
DEVICE

Comprehensive Reverse Versa-Dial Titanium Glenosphere

Implant used for patients with allergy to typical device material metals to repair shoulder malfunction/disease.

Trial Locations (2)

14215

University of Buffalo, Buffalo

40241

Norton Orthopaedic and Sports Medicine, Louisville

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY